Together Pharma News
31 articles
BHP Xplor Opens Applications for 2026 Cohort, Offering Equity-Free Funding and Global Support
BHP Group Limited has announced the opening of applications for the 2026 cohort of its BHP Xplor accelerator program, which aims to transform the discovery of critical minerals. The program offers early-stage explorers up to USD $500,000 in equity-free funding, mentorship, and access to BHP’s global network. BHP Xplor has been successful in previous years, fostering partnerships and accelerating exploration projects. The program supports BHPs long-term growth by engaging with diverse exploration projects. Applications are open from September 8 to October 15, 2025.
Partners
Westin Desaru Coast Resort partners with CAYIN Technology for digital signage
CAYIN Technology has partnered with Westin Desaru Coast Resort in Johor, Malaysia, to enhance guest communication and operational efficiency through the implementation of its CMS-WS server and CAYIN Signage Player. This collaboration involves the use of digital signage to provide real-time updates across 14 Samsung displays in various areas of the resort. The project was executed in partnership with Hola Media, which provided integration services, including installation, design, staff training, and support. The system has improved communication, reduced staff workload, and enhanced the guest experience, preparing the resort for future digital expansion.
Partners
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 2025
Nikkiso Clean Energy & Industrial Gases Group (Nikkiso CE&IG) announced the launch of a next-generation submerged ammonia pump at the Gastech Conference. This pump is designed to be the safest and most reliable in the industry, addressing common maintenance issues with its seal-less, maintenance-friendly, copper-free construction. The pump can deliver over 2,500m3 per hour and has a mean time between outages of over 16,000 hours. This launch is part of Nikkiso CE&IGs ongoing innovation in ammonia handling, with the company having decades of experience in this field. The pump is expected to meet growing demand for ammonia in various sectors, including power generation and shipping.
Product Stage
Assessing the Valuation of Yue Yuen Industrial (SEHK:551) After Recent Volatility
Yue Yuen Industrial (Holdings) has experienced notable stock price fluctuations, drawing attention from investors. Despite a year-to-date decline of 21%, the company has shown resilience with an 11% gain over the past year and a 13% increase in the past three months. Over a longer period, the stock is up 53% over three years and 44% over five years. The companys P/E ratio of 7.2x suggests it is undervalued compared to industry peers, indicating potential for growth if profit levels are sustained or improved. While the company shows steady revenue and net income growth, risks remain due to inconsistent short-term returns and potential shifts in market sentiment.
Nifty clocks fifth session of gains led by IT on Infosys buyback, US rate cut hopes
Infosys led gains in Indias Nifty 50 index, which closed higher for the fifth consecutive session, driven by a 5% surge in Infosys shares following the announcement of a share buyback plan. The IT sector, which accounted for a significant portion of the days gains, benefited from expectations of a U.S. interest rate cut, which could boost technology spending in the U.S., a key market for Indian IT firms. The broader market also saw gains, with the Nifty 50 and BSE Sensex both rising by 0.39%. The anticipation of a Federal Reserve rate cut was fueled by weaker-than-expected U.S. job data.
Cantourage, Cannabis House and Together Pharma partner to increase availability of medical cannabis in Poland
Cantourage, Cannabis House and Together Pharma partner to increase availability of medical cannabis in Poland
Cantourage Group SE, Cannabis House, and Together Pharma have announced a partnership to make Ugandan medical cannabis available in Poland for the first time. Polish patients enrolled in the Cannabis House initiative will have access to Together Pharmas Glueberry OG® cultivar, which will be distributed through selected pharmacies. This partnership expands access to medical cannabis products for patients in Poland and strengthens Together Pharmas position in the European market. The supply agreement includes the importation of over 500 kg of finished dried cannabis flowers over the next three years. Cantourage offers a range of medical cannabis products and is listed on the Frankfurt Stock Exchange.
Partners
494% Increase in Assets to US$33 million Israeli Cannabis Technology Company BYND Cannasoft Enterprises Inc. Poised for Growth
Tel Aviv Listed Together Pharma’s Subsidiary Globus Pharma Ltd and BYND Cannasoft Enterprises’ Subsidiary Sign First Commercial Agreement for Medical Cannabis Products
Together Pharma sells first medical cannabis in Germany
Together Pharma, an Israeli medical cannabis company, has sold its first 50 kilograms of medical cannabis inflorescences in Germany. The cannabis was cultivated at the companys farm in Uganda. Together Pharma plans to continue importing into Germany to supply the market with medical cannabis on a regular basis and capture a large market share. The German market is still in its infancy, providing an opportunity for Together Pharma to establish market leadership. The company is in contact with other strategic customers to sell significant amounts of medical cannabis produce. The German market prices medical cannabis significantly higher than pharmacies in Israel. This development creates a parallel revenue channel for Together Pharma, independent of its activities in Israel.
CustomersExpand
Together subsidizes sales for medical cannabis export permit
Together Pharma is participating in a cannabis export pilot project by Israels Ministry of Health. The pilot project aims to expedite export permits for companies that subsidize the price of medical cannabis products for the Israeli market. Together Pharma plans to offer a significant discount on its products in Israel and apply for an export permit to expand internationally. The company is completing the construction of its factory and trading offices, which will have a production capacity of about 50 tons of medical cannabis inflorescences annually. Together Pharma aims to sell medical cannabis to target markets in Europe and Brazil, both from Israel and from Uganda.
Expand
Israeli medical cannabis co Together signs Brazilian deal
Together, an Israeli medical cannabis company, has signed a distribution deal to market and distribute medical cannabis products in the Brazilian market. The company plans to focus on selling enriched CBD oils for treating epilepsy. The Brazilian market is seen as having major economic potential due to its large population. Brazil has approved the medical cannabis sector, allowing patients to buy cannabis products in pharmacies with a medical prescription. However, local cultivation and production facilities have been rejected, leading to the importation of cannabis products. Together estimates that developing the medical cannabis sector in Brazil can make it the worlds largest market for importing cannabis.
PartnersCustomers
Israel-based Together Pharma Snags Permit To Import Cannabis From Uganda - Benzinga
Cannabis company Together Pharma has received a permit to import an additional 600 kilograms of GACP medical cannabis from a farm in Uganda. The imported produce will be processed at Togethers GMP-certified production facility in Israel. The company has already shipped 250 kilograms from a Uganda farm and is currently marketing those products to pharmacies in Israel. Together Pharma has signed an exclusivity agreement with a pharmacy in Tel Aviv for distribution, and plans to expand its market share. The company is also working on agreements for global expansion and is constructing a processing plant for larger quantities of cannabis from both Uganda and Israel.
PartnersCustomersExpand
Together wins medical cannabis export permit from Uganda
Together Pharma, an Israeli medical cannabis company, has received approval to export medical cannabis to Germany, Malta, and Israel. The company has a farm in Uganda that has received Good Agricultural and Collection Practices (GACP) certification from the World Health Organization. Together Pharma aims to provide medical cannabis of the highest standards to the European market and the Israeli market, which is experiencing a shortage. The company is completing commercial agreements with EU-GMP certified plants in EU member countries. This move is expected to have a positive impact on the companys growth.
CustomersPartners
Together signs NIS 192m deal to grow cannabis for Canna-Tech
Together Pharma, an Israeli cannabis cultivation and production company, has signed a deal worth at least NIS 192.5 million with Canna-Tech. Together Pharma will cultivate at least five tons of medical cannabis annually for Canna-Tech at its Ashkelon farm. The deal also includes packing services provided by Together Pharma. The agreement reflects the companys strategy to create large-scale revenue and promote its business plan. The partnership aims to bring a new line of cannabis products to the Israeli and global market. The deal was supported by legal experts in international cannabis regulation.
PartnersInvestment
Together awarded medical cannabis commercial license
Together Pharma has been awarded a license from the Ministry of Healths Medical Cannabis Unit for commercial operations of its farm in Israel. The company plans to immediately start planting on a significant scale and supply medical cannabis produce to patients and pharmacies in Israel within a few months. This will help alleviate the recent shortage of medical cannabis products in the country. The company believes that the sales from the cultivation farm will position them as a leading medical cannabis company in Israel and abroad.
Customers
Together begins growing cannabis commercially in Israel
Together Pharma has switched to commercial cultivation at its farm in Ashkelon after receiving IMC-GAP approval. The company plans to supply medical cannabis products to pharmacies and patients in Israel, addressing the recent shortage. They will also produce cannabis oil products under the Cannabliss brand. Together Pharma has completed the acquisition of Cannabliss, a medical cannabis company, and will continue to manage it. Together Pharma is also involved in the CBD-based cosmetics field with Premier Dead Sea. They plan to manufacture approved products containing CBD ingredients. The company aims to market its products in Europe once export approval is obtained.
CustomersPartnersAcquisition
Medical Cannabis Company Together Plans to List Subsidiary Cannabliss in North America
Together Pharma Ltd. plans to list its subsidiary Cannabliss Ltd. through a North American IPO with a valuation between $40 million and $50 million. Together Pharma acquired Cannabliss for NIS 14 million. As part of the IPO preparation, Citrine Cannabis GP and iCAN: Israel-Cannabis will invest $900,000 in Cannabliss for a 15% stake.
Public TradingInvestment
Consumer Electronics Importer Ralco Wants In on the Green Gold
Ralco has announced a $5.66 million investment in Israeli medical cannabis company Together Pharma, acquiring an 11.5% stake in the company. Ralco will also provide a $1.56 million loan to Together Pharma. The investment is pending regulatory approval and completion of due diligence by December 31. Together Pharma has medical cannabis greenhouses in Israel and a farm in Uganda. The investment will be used to complete manufacturing facilities in Israel and Uganda.
Investment
Together's Ugandan cannabis farm wins WHO approval
Together Pharma, an Israeli medical cannabis company, has received approval for its farm in Uganda to meet the CUMCS-GAP standard, allowing it to sell its produce in European countries. The company is in talks with an EU-GMP approved facility in Europe to manufacture its products according to the GACP procedures. Together Pharma is also setting up a packaging and extraction factory adjacent to its Uganda farm and aims to receive the EU-GMP standard by the first quarter of 2020. The company plans to sell its medical cannabis products in pharmacies in Europe and is working on agreements with factories in European countries. Together Pharmas chairman is Yohanan Danino, former Israel police chief.
PartnersExpand
Medical Cannabis Company Together Pharma to Expand Into China
An unidentified Chinese corporation has invested $1 million in Together Pharma Ltd., a company focused on growing, exporting, and distributing medical cannabis. The two companies will establish a joint 20,000-square-meter cannabis farm in China, with Together Pharma providing expertise in growing and processing medical cannabis products. The Chinese company will cover the full cost of setting up the new facility. Together Pharma is a result of a 2017 merger and has previously formed partnerships in the skincare industry and acquired another company.
InvestmentPartners
Together Pharma to begin planting at Israeli cannabis farm
Together Pharma has received a license from Israels Ministry of Health to cultivate cannabis plants at its Ashkelon farm. This license is part of the regulatory process to comply with the IMC-GAP standard and obtain a permanent license for cultivation. The companys CEO, Nissim Beracha, highlighted the importance of this milestone and the companys progress in various countries. Together Pharma is also working on constructing a GMP standard factory in Israel and completing the acquisition of a German company with import and distribution approvals. The company aims to generate sales and profits and create value for its shareholders.
CustomersPartnersAcquisition
Danino: Decriminalize cannabis but don't legalize it
Former Israel Police Commissioner and chairman of cannabis company Together Pharma, Yohanan Danino, spoke at the Globes Cannabis conference in Tel Aviv. He expressed his opposition to the full legalization of cannabis but supported decriminalization. Danino emphasized the need for criminal reform and highlighted the benefits of medical cannabis for patients. He also discussed the involvement of celebrities in the cannabis sector and the importance of research and development. Additionally, Danino mentioned his investment in a digital insurance company and expressed his hope for its future success. The article does not mention any specific impact on the company or any partners, customers, or financial figures.
Customers
Medical Cannabis Company Together Pharma to Acquire Jerusalem-based Cannabliss for $3.9 Million
Tel Aviv-listed Together Pharma is acquiring Cannabliss for NIS 14 million ($3.9 million). Cannabliss develops and manufactures smoke-free cannabis products. Together Pharma was created from a merger in December 2017 and has partnerships in the skincare industry.
Acquisition
Israeli Insurance Firm Invests Over $2M In Local Medical Cannabis Company
Together Pharma, an Israeli medical cannabis company, has signed a deal with Hachshara Insurance Company for a NIS 10 million ($2.79 million) investment. In exchange, Hachshara will hold 4.76 percent of Togethers shares. The investment brings Together Pharmas value to an estimated NIS 200 million ($55.78 million). Together Pharma is focused on cultivating, producing, and marketing medical cannabis and is one of the first medical cannabis companies to be traded on the Tel Aviv Stock Exchange. The company plans to expand its presence in Israel and abroad, including the construction of an export plant for the EU-GMP-Cannabis export market in Germany. Together Pharma is also in the process of obtaining permits to export and distribute medical cannabis products throughout Europe.
Investment
https://nilepost.co.ug/2019/04/17/israeli-company-given-green-light-to-start-marijuana-farm-in-uganda/
Together, Premier Dead Sea begin making cannabis-based cosmetics
Together, a company specializing in cultivating and producing medical cannabis, has started manufacturing cosmetic products in partnership with Premier Dead Sea. The products will include CBD, a natural extract from the cannabis plant known for its therapeutic influences. The manufacturing will focus on three products: therapeutic oil, ointment for easing pains, and multi-purpose cream. The products will be marketed in countries where CBD extracts are legal and do not require a doctors prescription, such as Canada and many European countries. Togethers CEO believes that Premier, with its global outlets, will lead the marketing of the products and aims to achieve serial production in the first half of 2019.
PartnersCustomers
Together buys German co with cannabis import license
Israeli medical cannabis company Together has acquired control of a German company in the medical cannabis sector. Together will acquire 50.1% of the German company for €2 million and will become the controlling owner of a cannabis distributor in Germany. Together plans to import and distribute medical cannabis products in Germany and conduct R&D into unique varieties of medical cannabis. The company estimates it will be able to sell dried inflorescences for €10-12 per gram directly to pharmacies in Germany. The acquisition will position Together as a leading medical cannabis producer and supplier in the global market.
AcquisitionPartners
http://uk.businessinsider.com/r-israels-together-to-buy-control-of-german-cannabis-customer-2018-8
Medical Cannabis Company Together Pharma to Set Up Skincare Company
Together Pharma Ltd. is partnering with Israeli cosmetics and skincare company Premier Dead Sea to set up a skincare subsidiary. The subsidiary will incorporate CBD components supplied by Together and Dead Sea mineral-based creams supplied by Premier. The partnership is contingent on the successful integration of CBD in Premiers products. Together Pharma Ltd. has seen a 4% increase in stock value following the announcement. The use of CBD in skincare products has gained popularity, with several companies launching their own CBD-infused products. Dead Sea Minerals have also been used in skincare for decades. Together Pharma Ltd. is an Israel-based company focused on growing, exporting, and distributing medical cannabis.
Partners
Globus Pharma Plans to Build the Largest Greenhouse Compound in Israel - CashCropToday
